NEUTROGENA CLINICAL LIFTING WRINKLE TREATMENT SYSTEM- avobenzone, homosalate, octisalate, octocrylene, and oxybenzone cream

Neutrogena Clinical Lifting Wrinkle Treatment System by

Drug Labeling and Warnings

Neutrogena Clinical Lifting Wrinkle Treatment System by is a Otc medication manufactured, distributed, or labeled by Johnson & Johnson Consumer Inc.. Drug facts, warnings, and ingredients follow.

Drug Details [pdf]

Warning

For external use only. Avoid contact with eyes. If contact occurs, flush thoroughly with water. Discontinue use if irritation or rash appear.

Keep out of reach of children. If swallowed, get medical help or contact a Poison Control Center immediately.

Active Ingredients

Avobenzone 3%, Homosalate 12%, Octisalate 5%, Octocrylene 5%, Oxybenzone 3%

Inactive Ingredients

Water
Butylene Glycol
C12-15 Alkyl Benzoate
Tetrahydroxypropyl Ethylenediamine
Silica
Cetearyl Alcohol
Cyclopentasiloxane
Dimethicone
Steareth-2
Glyceryl Stearate
Steareth-21
Aluminum Starch Octenylsuccinate
Cetearyl Glucoside
C13-14 Isoparaffin
Dimethicone/Vinyl Dimethicone Crosspolymer
Arachidyl Alcohol
PEG-100 Stearate
Disodium EDTA
Polyacrylamide
Behenyl Alcohol
Acrylates/C10-30 Alkyl Acrylate Crosspolymer
Propylparaben
Pentaerythrityl Tetra-di-t-butyl Hydroxyhydrocinnamate
Arachidyl Glucoside
Laureth-7
Citric Acid
Benzyl Alcohol
Phenoxyethanol
Methylparaben
Ethylparaben
Fragrance

Questions

1-800-582-4048 or www.neutrogena.com

PRINCIPAL DISPLAY PANEL - Kit Carton

NEW

Neutrogena
clinical™

lifting wrinkle treatment system

visibly smoothes wrinkles and firms
for a resilient, youthful look

STARTER SYSTEM
SPF 30 EYE

helloplex®

with
ion2complex™

gel serum    +

spf 30 activating  +; cream

eye activating; cream

GEL SERUM 0.5 FL OZ (14mL) SPF 30 ACTIVATING CREAM 0.33 FL OZ (10mL)
EYE ACTIVATING CREAM 0.17 FL OZ (5mL)

INGREDIENTS AND APPEARANCE

NEUTROGENA CLINICAL LIFTING WRINKLE TREATMENT SYSTEM 
avobenzone, homosalate, octisalate, octocrylene, and oxybenzone cream

Product Information
Product Type	HUMAN OTC DRUG	Item Code (Source)	NDC: 10812-130
Route of Administration	TOPICAL

Active Ingredient/Active Moiety
Ingredient Name	Basis of Strength	Strength
Avobenzone (UNII: G63QQF2NOX) (Avobenzone - UNII:G63QQF2NOX)	Avobenzone	30 mg  in 1 mL
Homosalate (UNII: V06SV4M95S) (Homosalate - UNII:V06SV4M95S)	Homosalate	120 mg  in 1 mL
Octisalate (UNII: 4X49Y0596W) (Octisalate - UNII:4X49Y0596W)	Octisalate	50 mg  in 1 mL
Octocrylene (UNII: 5A68WGF6WM) (Octocrylene - UNII:5A68WGF6WM)	Octocrylene	50 mg  in 1 mL
Oxybenzone (UNII: 95OOS7VE0Y) (Oxybenzone - UNII:95OOS7VE0Y)	Oxybenzone	30 mg  in 1 mL

Inactive Ingredients
Ingredient Name	Strength
Water (UNII: 059QF0KO0R)

Packaging
#	Item Code	Package Description	Marketing Start Date	Marketing End Date
1	NDC: 10812-130-90	1 in 1 KIT	04/15/2010	12/01/2023
1		10 mL in 1 BOTTLE, PUMP; Type 0: Not a Combination Product

Marketing Information
Marketing Category	Application Number or Monograph Citation	Marketing Start Date	Marketing End Date
OTC monograph final	part352	04/15/2010	12/01/2023

Labeler - Johnson & Johnson Consumer Inc. (002347102)